Study ID: TVP - 1012/135 Open Label

Study Title

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Teva Identifier

TVP - 1012/135 Open Label

ClinicalTrials.gov Identifier

NCT00203164

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: rasagiline mesylate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years and older

Trial Duration

05/01/2002 - 09/01/2006

Phase

Phase 3

Study Type

Interventional